RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 12-22
  • China fines drugmaker GlaxoSmithKline $492 million in bribery case

    China fines drugmaker GlaxoSmithKline $492 million in bribery case
    China on Friday leveled a half-billion-dollar fine against British drugmaker GlaxoSmithKline after an investigation concluded that the company bribed physicians and hospitals to use its products. One company executive was given a suspended three-year...
  • Looking Out: Court deciding if sexual orientation can impact jury selection

    Looking Out: Court deciding if sexual orientation can impact jury selection
    Despite numerous marriage equality-related cases currently making their way through the judicial system, it's somehow the hot-button area of antitrust law where an important LGBT rights issue is taking place. The Associated Press reported Wednesday that...
  • China trying to pull back on gift-giving

    China trying to pull back on gift-giving
    BEIJING — If you want a full-time teaching job, but you're stuck in a temporary gig without health benefits, Luo Chunlei advises that you buy the school principal a box of mooncakes and follow up with an envelope of dough. Having an operation?...
  • Animal studies riddled with bias, report finds

    Animal studies riddled with bias, report finds
    Too much good news in medicine may be bad news for science, according to a new study that suggests animal research is riddled with bias that allows too many treatments to advance to human trials. Researchers examined data from thousands of experiments...
  • U.S. HPV vaccination rates far from goal, officials say

    U.S. HPV vaccination rates far from goal, officials say
    WASHINGTON (Reuters) - Only slightly more than half of U.S. girls aged 13 to 17 had been vaccinated against a virus that can cause cervical and other cancers last year, and a top U.S. health official said on Thursday that more must be done to bring the...
  • Deals of the day -- mergers and acquisitions

    July 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** Dell Inc founder Michael Dell raised his $24.4 billion bid by less than 1 percent just hours before it was to be put to a vote,...
  • LGBT ally groups can improve an office

    LGBT ally groups can improve an office
    As human beings, we are at our best when we can be ourselves, when we live without fear of judgment or the pressures of putting on airs. As workers, logically, it's no different. An employee living authentically, unencumbered by the distractions of...
  • 9th Circuit bans juror exclusion over sexual orientation

    SAN FRANCISCO — A federal appeals court became the first in the nation to rule that prospective jurors may not be excluded because of their sexual orientation, a decision that expands juror protections beyond race and gender and provides legal...
  • Looking Out: Jurors can't be excluded based on sexual orientation, court says

    Looking Out: Jurors can't be excluded based on sexual orientation, court says
    In a decision with wide-reaching implications, a federal appeals court ruled this week that potential jurors cannot be left off of juries based on their sexual orientations. Remember the antitrust case involving two purveyors of HIV/AIDS drugs that...
  • FDA affirms safety of diabetes drug Avandia, lifts restrictions on use

    FDA affirms safety of diabetes drug Avandia, lifts restrictions on use
    Avandia, a controversial diabetes drug that was thought to increase patients’ risk of heart attacks and other cardiovascular problems, has been cleared for widespread use by the Food and Drug Administration. Federal regulators said Monday that the...
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...